Uterine myomata and outcome of assisted reproduction.
The aim of this work was to study the effect of uterine myomata on the implantation rate and outcome in in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Among 406 patients, 51 (12.6%) were found to have uterine corporeal myomata. Twelve patients were excluded from the study as they had large myomata, submucous myomata or intramural myomata encroaching on the cavity. These patients were advised to have myomectomy before being enrolled in the IVF/ICSI programme. The remaining patients (n = 39) were sorted according to the number, site and size of the myomata as assessed by transvaginal sonography. Three patients had more than one myoma. Most of the myomata were subserous (72.7%) and the mean diameter of the myomata was 3.5 +/- 0.9 cm. A control group (n = 367) was chosen with normal uteri and no history of uterine reconstruction surgery. The mean age of myoma patients was 34.7 +/- 3.6 years as compared to 34.0 +/- 4.4 years in the control group. The age, period of infertility, body mass index, duration and number of human menopausal gonadotrophin ampoules needed for stimulation, oestradiol levels, number of oocytes retrieved and the fertilization rate were not significantly different in the myoma patients compared to the control group. Fifteen myoma patients (38.5%) subsequently showed one or more pregnancy sacs on ultrasonography of which three (20%) spontaneously aborted during the first trimester and two (13.3%) had preterm labour, as compared to 123 (33.5%), 19 (15.5%) and nine (7.3%) respectively, among the control group (P = 0.27, 0.33 and 0.21). In conclusion, uterine corporeal myomata, not encroaching on the cavity and <7 cm in mean diameter, do not affect the implantation or miscarriage rates in IVF or ICSI.
Ramzy
A M
AM
The Egyptian IVF-ET Centre, Department of Obstetrics and Gynaecology, Cairo University, Egypt.
Sattar
M
M
Amin
Y
Y
Mansour
R T
RT
Serour
G I
GI
Aboulghar
M A
MA
D000328:Adult; D003593:Cytoplasm; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D015994:Incidence; D007889:Leiomyoma / Q000453:epidemiology / Q000503:physiopathology*; D008297:Male; D008423:Maternal Age; D008845:Microinjections; D011247:Pregnancy; D011256:Pregnancy Outcome; D018566:Pregnancy, High-Risk; D012189:Retrospective Studies; D013084:Sperm-Ovum Interactions; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000453:epidemiology / Q000503:physiopathology*; D014599:Uterus / Q000098:blood supply*